Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma

References

• European Association For The Study of The Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.01929628281
   PubMed Web of Science ®Google Scholar
• VargheseJ, KedarisettyC, VenkataramanJ, et al. Combination of TACE and sorafenib improves outcomes in BCLC stages B/C of hepatocellular carcinoma: a single centre experience. Ann Hepatol. 2017;16(2):247–254. doi:10.5604/16652681.123158528233748
   PubMed Web of Science ®Google Scholar
• PanT, LiXS, XieQK, et al. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. Clin Radiol. 2014;69(12):e553–561. doi:10.1016/j.crad.2014.09.00725304928
   PubMed Web of Science ®Google Scholar
• KonnoT, MaedaH, IwaiK, et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol. 1983;19(8):1053–1065. doi:10.1016/0277-5379(83)90028-76311559
   PubMedGoogle Scholar
• NakamuraH, HashimotoT, OiH, SawadaS. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology. 1989;170(3 Pt 1):783–786. doi:10.1148/radiology.170.3.25369462536946
   PubMed Web of Science ®Google Scholar
• BrownDB, GouldJE, GervaisDA, et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;20(7 Suppl):S425–434. doi:10.1016/j.jvir.2009.04.02119560030
   PubMed Web of Science ®Google Scholar
• VarelaM, RealMI, BurrelM, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46(3):474–481.17239480
   PubMed Web of Science ®Google Scholar
• SottaniC, PoggiG, QuarettiP, et al. Serum pharmacokinetics in patients treated with transarterial chemoembolization (TACE) using two types of epirubicin-loaded microspheres. Anticancer Res. 2012;32(5):1769–1774.22593459
   PubMed Web of Science ®Google Scholar
• JiaqiY, HoriS, MinamitaniK, et al. [A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects]. Nihon Igaku Hoshasen Gakkai Zasshi. 1996;56(1):19–24.8857094
   PubMedGoogle Scholar
• NouriYM, KimJH, YoonH-K, KoH-K, ShinJH, GwonDI. Update on transarterial chemoembolization with drug-eluting microspheres for hepatocellular carcinoma. Korean J Radiol. 2019;20(1):34–49. doi:10.3348/kjr.2018.008830627020
   PubMed Web of Science ®Google Scholar
• MoustafaAS, Abdel AalAK, ErtelN, SaadN, DuBayD, SaddekniS. Chemoembolization of hepatocellular carcinoma with extrahepatic collateral blood supply: anatomic and technical considerations. Radiographics. 2017;37(3):963–977. doi:10.1148/rg.201716012228362557
   PubMed Web of Science ®Google Scholar
• WatanabeY, TokueH, Taketomi-TakahashiA, TsushimaY. Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma. Eur J Radiol Open. 2018;5:171–176. doi:10.1016/j.ejro.2018.08.01030263910
   PubMed Web of Science ®Google Scholar
• NhuQM, KnowlesH, PockrosPJ, FrenetteCT. Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Respirol. 2016;6(3):69–75. doi:10.5320/wjr.v6.i3.6927904836
   PubMedGoogle Scholar
• ChungJW, ParkJH, HanJK, ChoiBI, KimTK, HanMC. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol. 1998;9(3):495–500. doi:10.1016/S1051-0443(98)70306-99618112
   PubMed Web of Science ®Google Scholar
• KohS, MakiEJ, KolbeckKJ, FarsadK. Skin ischemia and ulceration as a complication of inferior phrenic artery embolization for hepatocellular carcinoma. Radiol Case Rep. 2018;13(3):648–651. doi:10.1016/j.radcr.2018.02.03230038697
   PubMedGoogle Scholar
• MarreroJA, KulikLM, SirlinCB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68(2):723–750.29624699
   PubMed Web of Science ®Google Scholar
• KudoM, IzumiN, IchidaT, et al. Report of the 19th follow-up survey of primary liver cancer in Japan. Hepatol Res. 2016;46(5):372–390. doi:10.1111/hepr.1269726970231
   PubMed Web of Science ®Google Scholar
• MeiQ, LiY. Transcatheter arterial embolization of hepatic arteriovenous shunts in patients with hepatocellular carcinoma. Semin Intervent Radiol. 2012;29(3):237–240. doi:10.1055/s-0032-132693523997418
   PubMedGoogle Scholar
• TacherV, RadaelliA, LinM, GeschwindJ-F. How I do it: cone-beam CT during transarterial chemoembolization for liver cancer. Radiology. 2015;274(2):320–334. doi:10.1148/radiol.1413192525625741
   PubMed Web of Science ®Google Scholar
• JinB, WangD, LewandowskiRJ, et al. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2011;196(4):919–928. doi:10.2214/AJR.10.477021427346
   PubMed Web of Science ®Google Scholar
• LencioniR, LlovetJM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60. doi:10.1055/s-0030-124713220175033
   PubMed Web of Science ®Google Scholar
• WangW-D, ZhangL-H, NiJ-Y, et al. Radiofrequency ablation combined with transcatheter arterial chemoembolization therapy versus surgical resection for hepatocellular carcinoma within the milan criteria: a meta-analysis. Korean J Radiol. 2018;19(4):613–622.29962868
   PubMed Web of Science ®Google Scholar
• SongMJ, ChunHJ, SongDS, et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol. 2012;57(6):1244–1250. doi:10.1016/j.jhep.2012.07.01722824821
   PubMed Web of Science ®Google Scholar
• LammerJ, MalagariK, VoglT, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33(1):41–52. doi:10.1007/s00270-009-9711-719908093
   PubMed Web of Science ®Google Scholar
• LeeYK, JungKS, KimDY, et al. Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: emphasis on the impact of tumor size. J Gastroenterol Hepatol. 2017;32(2):487–496. doi:10.1111/jgh.1350127503585
   PubMed Web of Science ®Google Scholar
• MiyayamaSH, MatsuiOS. Applying superselective conventional TACE. Endovasc Today. 2017;16:52–56.
   Google Scholar
• DreherMR, SharmaKV, WoodsDL, et al. Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine. J Vasc Interv Radiol. 2012;23(2):257–264.e254. doi:10.1016/j.jvir.2011.10.01922178039
   PubMed Web of Science ®Google Scholar
• PrajapatiHJ, XingM, SpiveyJR, et al. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC. AJR Am J Roentgenol. 2014;203(6):W706–714. doi:10.2214/AJR.13.1230825415737
   PubMed Web of Science ®Google Scholar
• GolfieriR, GiampalmaE, RenzulliM, et al. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer. 2014;111:255. doi:10.1038/bjc.2014.19924937669
   PubMed Web of Science ®Google Scholar
• LucatelliP, CoronaM, ArgiròR, et al. Impact of 3D rotational angiography on liver embolization procedures: review of technique and applications. Cardiovasc Intervent Radiol. 2015;38(3):523–535. doi:10.1007/s00270-014-1023-x25488820
   PubMed Web of Science ®Google Scholar
• LucatelliP, ArgiròR, Ginanni CorradiniS, et al. Comparison of image quality and diagnostic performance of cone-beam CT during drug-eluting embolic transarterial chemoembolization and multidetector CT in the detection of hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28(7):978–986.28495451
   PubMed Web of Science ®Google Scholar
• LucatelliP, De RubeisG, Ginnani CorradiniL, et al. Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure. Eur J Radiol. 2020;124:108806. doi:10.1016/j.ejrad.2019.10880631945673
   PubMed Web of Science ®Google Scholar
• LucatelliP, De RubeisG, BasilicoF, et al. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE. Radiol Med. 2019;124(12):1212–1219. doi:10.1007/s11547-019-01076-y31473930
   PubMed Web of Science ®Google Scholar
• LucatelliP, ArgiròR, BascettaS, et al. Single injection dual phase CBCT technique ameliorates results of trans-arterial chemoembolization for hepatocellular cancer. Transl Gastroenterol Hepatol. 2017;2:83. doi:10.21037/tgh.2017.10.0329167830
   PubMed Web of Science ®Google Scholar
• KimHC, ChungJW, ParkJH, et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma: prospective assessment of the right inferior phrenic artery with C-arm CT. J Vasc Interv Radiol. 2009;20(7):888–895. doi:10.1016/j.jvir.2009.03.03619481471
   PubMed Web of Science ®Google Scholar
• KimH-C. Role of C-arm cone-beam CT in chemoembolization for hepatocellular carcinoma. Korean J Radiol. 2015;16(1):114–124. doi:10.3348/kjr.2015.16.1.11425598679
   PubMed Web of Science ®Google Scholar